Intermittent dobutamine treatment in patients with chronic refractory congestive heart failure: a randomized, double-blind, placebo-controlled study (Q74776183)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 June 1998

Language	Label	Description	Also known as
English	Intermittent dobutamine treatment in patients with chronic refractory congestive heart failure: a randomized, double-blind, placebo-controlled study	scientific article published on 01 June 1998

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663183%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Intermittent dobutamine treatment in patients with chronic refractory congestive heart failure: a randomized, double-blind, placebo-controlled study (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663183%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

congestive heart failure

1 reference

based on heuristic

inferred from title

author name string

Elis A

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663183%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Bental T

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663183%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Kimchi O

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663183%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Ravid M

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663183%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Lishner M

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663183%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

publication date

1 June 1998

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663183%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Clinical Pharmacology & Therapeutics

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663183%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

63

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663183%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663183%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

682-685

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663183%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Dobutamine: development of a new catecholamine to selectively increase cardiac contractility

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990092-3

7 January 2021

Acute effects of dobutamine on myocardial oxygen consumption and cardiac efficiency measured using carbon-11 acetate kinetics in patients with dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990092-3

7 January 2021

Effect of dobutamine on pulmonary gas exchange in patients with severe heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990092-3

7 January 2021

Effects of short-term administration of dobutamine on left ventricular performance, exercise capacity, norepinephrine levels, and lymphocyte adrenergic receptor density in congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990092-3

7 January 2021

Long-term benefit of dobutamine in patients with congestive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990092-3

7 January 2021

Sustained improvement of cardiac function in patients with congestive heart failure after short-term infusion of dobutamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990092-3

7 January 2021

Drug-induced conditioning in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990092-3

7 January 2021

Inotropic therapy of the failing myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990092-3

7 January 2021

Medical advances in the treatment of congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990092-3

7 January 2021

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990092-3

7 January 2021

A randomized comparison of intravenous amrinone versus dobutamine in older patients with decompensated congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990092-3

7 January 2021

Arterial hemodynamics and cardiac effects of enoximone, dobutamine, and their combination in severe heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990092-3

7 January 2021

Sudden death and staged therapy for hemodynamic stabilization in patients enrolled in a heart transplantation program

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990092-3

7 January 2021

Intermittent infusion of dobutamine in the therapy of severe congestive heart failure--long-term effects and lack of tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990092-3

7 January 2021

Intermittent dobutamine infusion in severe chronic heart failure in elderly patients

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990092-3

7 January 2021

Future approaches to pharmacologic therapy for congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2898%2990092-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0009-9236(98)90092-3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663183%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9663183%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q74776183&oldid=1899967624"